Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I results reported for analgesic CCR2 antagonist CNTX-6970

May 4, 2018

Abbisko presents novel candidates with promising preclinical profiles

May 4, 2018

Daiichi Sankyo profiles highlights of fourth quarter of fiscal 2017

May 4, 2018

Coherus BioSciences announces re-submission of BLA for CHS-1701

May 4, 2018

Azitra raises new financing to advance pipeline

May 4, 2018

Refuge Biotechnologies completes series B financing

May 4, 2018

FDA grants orphan drug designation to BN-Brachyury as treatment for chordoma

May 4, 2018

FDA advisory committee votes to recommend Siga's Tpoxx smallpox treatment

May 3, 2018

Heptares Therapeutics divulges novel M1 and/or M4 receptor agonists

May 3, 2018

Novel mutant IDH inhibitors presented by Isocure Biosciences

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...